Robert D. E. Sewell

3.6k total citations
173 papers, 2.8k citations indexed

About

Robert D. E. Sewell is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Robert D. E. Sewell has authored 173 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Cellular and Molecular Neuroscience, 64 papers in Molecular Biology and 55 papers in Physiology. Recurrent topics in Robert D. E. Sewell's work include Pain Mechanisms and Treatments (37 papers), Neuroscience and Neuropharmacology Research (32 papers) and Neurotransmitter Receptor Influence on Behavior (27 papers). Robert D. E. Sewell is often cited by papers focused on Pain Mechanisms and Treatments (37 papers), Neuroscience and Neuropharmacology Research (32 papers) and Neurotransmitter Receptor Influence on Behavior (27 papers). Robert D. E. Sewell collaborates with scholars based in United Kingdom, Pakistan and Russia. Robert D. E. Sewell's co-authors include P.S. Spencer, Alex M. Gray, Fazal Subhan, Khojasteh Malekmohammad, Mahmoud Rafieian‐Kopaei, David Pache, John P. Gonzalez, M. A. Gruden, Mahmoud Rafieian‐Kopaei and Muhammad Shahid and has published in prestigious journals such as PEDIATRICS, Biochemical and Biophysical Research Communications and British Journal of Pharmacology.

In The Last Decade

Robert D. E. Sewell

166 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert D. E. Sewell United Kingdom 28 1.1k 966 915 290 288 173 2.8k
Takeshi Tadano Japan 30 661 0.6× 858 0.9× 1.0k 1.1× 308 1.1× 249 0.9× 145 2.9k
Osamu Nakagawasai Japan 31 704 0.7× 947 1.0× 1.1k 1.2× 264 0.9× 263 0.9× 133 3.0k
Shogo Tokuyama Japan 33 939 0.9× 1.2k 1.2× 1.5k 1.6× 283 1.0× 164 0.6× 188 3.5k
Isaac Túnez Spain 37 780 0.7× 748 0.8× 1.2k 1.3× 269 0.9× 268 0.9× 162 4.3k
Carlos Fernando Mello Brazil 41 858 0.8× 1.4k 1.4× 1.7k 1.9× 588 2.0× 253 0.9× 164 4.6k
Hee Kee Kim United States 24 1.5k 1.4× 552 0.6× 827 0.9× 462 1.6× 194 0.7× 32 2.7k
Muralikrishnan Dhanasekaran United States 32 751 0.7× 625 0.6× 1.0k 1.1× 498 1.7× 313 1.1× 126 3.3k
Carlos Beas‐Zárate Mexico 34 1.1k 1.0× 1.1k 1.1× 1.2k 1.3× 434 1.5× 182 0.6× 125 3.6k
Keith Bley United States 23 1.2k 1.1× 1.4k 1.5× 1.7k 1.8× 425 1.5× 311 1.1× 39 3.6k
Christianne Gazzana Salbego Brazil 40 927 0.9× 676 0.7× 1.4k 1.5× 375 1.3× 162 0.6× 109 3.9k

Countries citing papers authored by Robert D. E. Sewell

Since Specialization
Citations

This map shows the geographic impact of Robert D. E. Sewell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert D. E. Sewell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert D. E. Sewell more than expected).

Fields of papers citing papers by Robert D. E. Sewell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert D. E. Sewell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert D. E. Sewell. The network helps show where Robert D. E. Sewell may publish in the future.

Co-authorship network of co-authors of Robert D. E. Sewell

This figure shows the co-authorship network connecting the top 25 collaborators of Robert D. E. Sewell. A scholar is included among the top collaborators of Robert D. E. Sewell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert D. E. Sewell. Robert D. E. Sewell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shahid, Muhammad Kashif, Fazal Subhan, Nisar Ahmad, et al.. (2024). 6-Methoxyflavone antagonizes chronic constriction injury and diabetes associated neuropathic nociception expression. Biochemical and Biophysical Research Communications. 724. 150217–150217.
3.
Mirza, Osman, et al.. (2024). Journal of Population and Therapeutics and Clinical Pharmacology. 1 indexed citations
4.
Sheibani, Vahid, et al.. (2023). Fraxetin attenuates disrupted behavioral and central neurochemical activity in a model of chronic unpredictable stress. Frontiers in Pharmacology. 14. 1135497–1135497. 10 indexed citations
5.
Ali, Gowhar, et al.. (2023). Effect of Gabapentin-Fluoxetine Derivative GBP1F in a Murine Model of Depression, Anxiety and Cognition. Drug Design Development and Therapy. Volume 17. 1793–1803. 2 indexed citations
6.
Sheibani, Vahid, et al.. (2023). Effects of 1-methyl-1, 2, 3, 4-tetrahydroisoquinoline on a diabetic neuropathic pain model. Frontiers in Pharmacology. 14. 1128496–1128496. 6 indexed citations
7.
Rauf, Khalid, et al.. (2022). 6-Methoxyflavone and Donepezil Behavioral Plus Neurochemical Correlates in Reversing Chronic Ethanol and Withdrawal Induced Cognitive Impairment. Drug Design Development and Therapy. Volume 16. 1573–1593. 7 indexed citations
8.
Ghazanfarpour, Masumeh, et al.. (2021). Effect of fennel on primary dysmenorrhea: a systematic review and meta-analysis. Journal of Complementary and Integrative Medicine. 18(2). 261–269. 8 indexed citations
9.
Ali, Gowhar, Umer Rashid, Rasool Khan, et al.. (2021). Mechanistic evaluation of a novel cyclohexenone derivative’s functionality against nociception and inflammation: An in-vitro, in-vivo and in-silico approach. European Journal of Pharmacology. 902. 174091–174091. 20 indexed citations
10.
Sewell, Robert D. E., et al.. (2019). Depression and Treatment with Effective Herbs. Current Pharmaceutical Design. 25(6). 738–745. 34 indexed citations
11.
Шерстнев, В. В., Robert D. E. Sewell, Kiran Yanamandra, et al.. (2014). PARKINSON'S DISEASE PROGRESSION. Journal of Neuroimmunology. 233(2011). 221–227. 9 indexed citations
12.
Gruden, M. A., et al.. (2014). Intranasal administration of alpha-synuclein aggregates: a Parkinson's disease model with behavioral and neurochemical correlates. Behavioural Brain Research. 263. 158–168. 17 indexed citations
13.
Gruden, M. A., et al.. (2013). Distinct functional brain regional integration of Casp3, Ascl1 and S100a6 gene expression in spatial memory. Behavioural Brain Research. 252. 230–238. 12 indexed citations
14.
Subhan, Fazal, Nasiara Karim, Anwarul Hassan Gilani, & Robert D. E. Sewell. (2009). Terpenoid content of Valeriana wallichii extracts and antidepressant‐like response profiles. Phytotherapy Research. 24(5). 686–691. 35 indexed citations
15.
Pache, David, et al.. (2003). Buspirone differentially modifies short-term memory function in a combined delayed matching/non-matching to position task. European Journal of Pharmacology. 477(3). 205–211. 10 indexed citations
16.
Subhan, Fazal, David Pache, & Robert D. E. Sewell. (2000). CCK2 receptor antagonism attenuates negative motivational properties and physical signs of morphine withdrawal. 11(1). 27–37. 2 indexed citations
17.
Subhan, Fazal, et al.. (2000). Do antidepressants affect motivation in conditioned place preference?. European Journal of Pharmacology. 408(3). 257–263. 38 indexed citations
18.
Rafieian‐Kopaei, Mahmoud & Robert D. E. Sewell. (1999). INVOLVEMENT OF THE SEROTONIN SYSTEM IN SSRI-INDUCED ANTINOCICEPTION. The Medical Journal of The Islamic Republic of Iran. 12(4). 359–364. 2 indexed citations
19.
Sewell, Robert D. E., et al.. (1996). Pharmacology Experimental Benefits from the Use of Computer-Assisted Learning. American Journal of Pharmaceutical Education. 60(3). 303–307. 21 indexed citations
20.
Spencer, P.S., et al.. (1995). Contrasting actions of acute or chronic paroxetine and fluvoxamine on morphine withdrawal-induced place conditioning. European Journal of Pharmacology. 275(2). 185–189. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takeshi Tadano Breakdown of academic impact, for papers by Osamu Nakagawasai Breakdown of academic impact, for papers by Shogo Tokuyama Breakdown of academic impact, for papers by Isaac Túnez Breakdown of academic impact, for papers by Carlos Fernando Mello Breakdown of academic impact, for papers by Hee Kee Kim Breakdown of academic impact, for papers by Muralikrishnan Dhanasekaran Breakdown of academic impact, for papers by Carlos Beas‐Zárate Breakdown of academic impact, for papers by Keith Bley Breakdown of academic impact, for papers by Christianne Gazzana Salbego
Rankless by CCL
2026